This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Vantage periodically executes a "State of Pharma AllianceManagement" report, based on surveys, benchmarking studies, and informal conversations with Heads of AllianceManagement across the industry.
Our team enjoyed presenting ( here's our presentation ) at Cambridge Healthtech Institute’s Strategic AllianceManagement Congress in Philadelphia earlier this month. This conference is an annual highlight for us!
Committed to operational excellence and best in class association management, ISTO has played a pivotal role in the formation of nearly 100 technical organizations over the past quarter century, enabling technology associations to collaborate successfully and fulfill the technology needs of of a wide range of industry ecosystems, e.g., power and energy, (..)
Leading alliances to the next level requires more than doing the same things better. Alliancemanagement practice can be complemented by analytic rigor, systems logic, and AI. This commitment positions BTD to help ASAP members drive alliancemanagement to a new level of performance.
With a 26-year background in lifesciences, Sharon specializes in the development and execution of strategic investor relations programs for public and pre-IPO companies in the lifesciences sector. Sharon Choe is the Senior Vice President & Head of Investor Outreach & Corporate Access at LaVoieHealthScience.
Leading alliances to the next level requires more than doing the same things better. Alliancemanagement practice can be complemented by analytic rigor, systems logic, and AI. This commitment positions BTD to help ASAP members drive alliancemanagement to a new level of performance.
We organize all of the trending information in your field so you don't have to. Join 61,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content